FDA-approved 2010 (Victoza, T2D) and 2014 (Saxenda, obesity)
injectable preparations reach the dermis, hair follicles, and healing tissue from the inside
They produce measurable pharmacological effects in humans, and ipamorelin has also been evaluated in a phase II clinical trial
This is where innovative nutrition-based interventions can play a pivotal role. The physicians group said using a SGLT-2 inhibitor such as Jardiance can reduce the risk of all-cause mortality, major adverse cardiovascular events, progression of chronic kidney disease, and hospitalization due to congestive heart failure
**Exercise schedule:** Patients who train intensely may find nausea and strenuous exercise a miserable combination
GI symptoms remain the most frequently observed side effects